Liberato LN - Search Results

1

An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression.

Barosi G, Buratti A, Costa A, Liberato LN, Balduini C, Cazzola M, Rosti V, Magrini U, Ascari E. Barosi G, et al. Among authors: liberato ln. Cancer. 1991 Nov 15;68(10):2310-8. doi: 10.1002/1097-0142(19911115)68:10<2310::aid-cncr2820681034>3.0.co;2-2. Cancer. 1991. PMID: 1913467

2

Induction and maintenance alpha-interferon therapy in myelofibrosis with myeloid metaplasia.

Barosi G, Liberato LN, Costa A, Buratti A, Di Dio F, Salvatore S, Ascari E. Barosi G, et al. Among authors: liberato ln. Eur J Haematol Suppl. 1990;52:12-4. doi: 10.1111/j.1600-0609.1990.tb00898.x. Eur J Haematol Suppl. 1990. PMID: 2279538

3

Serum procollagen-III-peptide level correlates with disease activity in myelofibrosis with myeloid metaplasia.

Barosi G, Costa A, Liberato LN, Polino G, Spriano P, Magrini U. Barosi G, et al. Among authors: liberato ln. Br J Haematol. 1989 May;72(1):16-20. doi: 10.1111/j.1365-2141.1989.tb07644.x. Br J Haematol. 1989. PMID: 2736239

4

Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia.

Barosi G, Liberato LN, Costa A, Ascari E. Barosi G, et al. Among authors: liberato ln. Blut. 1989 Jun;58(6):271-4. doi: 10.1007/BF00320164. Blut. 1989. PMID: 2736307

5

A prognostic classification of myelofibrosis with myeloid metaplasia.

Barosi G, Berzuini C, Liberato LN, Costa A, Polino G, Ascari E. Barosi G, et al. Among authors: liberato ln. Br J Haematol. 1988 Dec;70(4):397-401. doi: 10.1111/j.1365-2141.1988.tb02507.x. Br J Haematol. 1988. PMID: 3219290

6

Serum erythropoietin in patients with myelofibrosis with myeloid metaplasia.

Barosi G, Liberato LN, Guarnone R. Barosi G, et al. Among authors: liberato ln. Br J Haematol. 1993 Mar;83(3):365-9. doi: 10.1111/j.1365-2141.1993.tb04658.x. Br J Haematol. 1993. PMID: 8485043

7

Small-dose iron tolerance test and body iron content in normal subjects.

Costa A, Liberato LN, Palestra P, Barosi G. Costa A, et al. Among authors: liberato ln. Eur J Haematol. 1991 Mar;46(3):152-7. doi: 10.1111/j.1600-0609.1991.tb01269.x. Eur J Haematol. 1991. PMID: 2009948

8

Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation.

Locatelli F, Pedrazzoli P, Barosi G, Zecca M, Porta F, Liberato L, Gambarana D, Nespoli L, Cazzola M. Locatelli F, et al. Br J Haematol. 1992 Apr;80(4):545-9. doi: 10.1111/j.1365-2141.1992.tb04571.x. Br J Haematol. 1992. PMID: 1581240

9

Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.

Alessandrino EP, Amadori S, Barosi G, Cazzola M, Grossi A, Liberato LN, Locatelli F, Marchetti M, Morra E, Rebulla P, Visani G, Tura S; Italian Society of Hematology. Alessandrino EP, et al. Among authors: liberato ln. Haematologica. 2002 Dec;87(12):1286-306. Haematologica. 2002. PMID: 12495903

10

Fludarabine for chronic lymphocytic leukemia.

Marchetti M, Barosi G, Liberato LN. Marchetti M, et al. Among authors: liberato ln. N Engl J Med. 2001 Apr 12;344(15):1166-7; author reply 1167-8. doi: 10.1056/NEJM200104123441511. N Engl J Med. 2001. PMID: 11302140 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters